- Mitsui S, Yamada T, Okui A, Kominami K, Uemura H, Yamaguchi N (May 2000). "A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate". Biochemical and Biophysical Research Communications. 272 (1): 205–211. Bibcode:2000BBRC..272..205M. doi:10.1006/bbrc.2000.2761. PMID 10872828.
- Gan L, Lee I, Smith R, Argonza-Barrett R, Lei H, McCuaig J, et al. (October 2000). "Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region". Gene. 257 (1): 119–130. doi:10.1016/S0378-1119(00)00382-6. PMID 11054574.
- Nakamura T, Mitsui S, Okui A, Kominami K, Nomoto T, Ukimura O, et al. (September 2001). "Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines". The Prostate. 49 (1): 72–78. doi:10.1002/pros.1119. PMID 11550212. S2CID 21572408.
- Diamandis EP, Okui A, Mitsui S, Luo LY, Soosaipillai A, Grass L, et al. (January 2002). "Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma". Cancer Research. 62 (1): 295–300. PMID 11782391.
- Nakamura T, Mitsui S, Okui A, Miki T, Yamaguchi N (March 2003). "Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate". The Prostate. 54 (4): 299–305. doi:10.1002/pros.10191. PMID 12539228. S2CID 21482369.
- Nakamura T, Stephan C, Scorilas A, Yousef GM, Jung K, Diamandis EP (May 2003). "Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues". Urology. 61 (5): 1042–1046. doi:10.1016/S0090-4295(02)02443-3. PMID 12736044.
- Borgoño CA, Fracchioli S, Yousef GM, Rigault de la Longrais IA, Luo LY, Soosaipillai A, et al. (September 2003). "Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma". International Journal of Cancer. 106 (4): 605–610. CiteSeerX 10.1.1.623.9575. doi:10.1002/ijc.11296. PMID 12845660. S2CID 13671141.
\* Shigemasa K, Gu L, Tanimoto H, O'Brien TJ, Ohama K (April 2004). "Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer". Clinical Cancer Research. 10 (8): 2766–2770. doi:10.1158/1078-0432.CCR-03-0269. PMID 15102682. S2CID 1192794.
- Diamandis EP, Borgoño CA, Scorilas A, Harbeck N, Dorn J, Schmitt M (September 2004). "Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients". Clinical Biochemistry. 37 (9): 823–829. doi:10.1016/j.clinbiochem.2004.04.009. PMID 15329323.
- Stavropoulou P, Gregorakis AK, Plebani M, Scorilas A (July 2005). "Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer". Clinica Chimica Acta; International Journal of Clinical Chemistry. 357 (2): 190–195. doi:10.1016/j.cccn.2005.03.026. PMID 15893744.
- Planque C, Aïnciburu M, Heuzé-Vourc'h N, Régina S, de Monte M, Courty Y (June 2006). "Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues". Biological Chemistry. 387 (6): 783–788. doi:10.1515/BC.2006.098. PMID 16800740. S2CID 6937753.
- Mitsui S, Nakamura T, Okui A, Kominami K, Uemura H, Yamaguchi N (August 2006). "Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin". The FEBS Journal. 273 (16): 3678–3686. doi:10.1111/j.1742-4658.2006.05372.x. PMID 16911518. S2CID 25021929.
